Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-040393

Chief Financial Officer sold 15,000 shares at $74.01 ($1,110,150)

  • Chief Financial Officer acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gordon Stephen · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-01 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $38.46 $576,900 38,299 D
2024-04-01 Sale : show line 2 in the form 10b5-1 −15,000 $74.01 $1,110,150 23,299 D
Open-market sales · 15,000 sh · avg $74.01 · $1,110,150

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-01 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −15,000 37,477 D
Loading xslF345X05/ownership.xml…